These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5960847)

  • 1. [Rifamide and rifamycin SV: some comparative observations on kinetics in man].
    Acocella G; Pallanza R; Santilli E; Nicolis FB
    Antibiotica; 1966 Mar; 4(1):17-48. PubMed ID: 5960847
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies with a new rifamycin derivative.
    Cohn HD
    J Clin Pharmacol J New Drugs; 1969; 9(2):118-25. PubMed ID: 4889468
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renal elimination of rifamycin SV by patients with renal disease].
    Bianchi Porro G; Timbal MT
    Antibiotica; 1967 Jun; 5(2):114-27. PubMed ID: 5609361
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of intravenous rifamycin SV in the treatment of pulmonary tuberculosis].
    Toussaint P; Dierckx JP; Toussaint-Francx Y
    Acta Tuberc Pneumol Belg; 1967; 58(3):169-78. PubMed ID: 6082771
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of bilirubin excretion in man during dehydrocholate choleresis.
    Bloomer JR; Boyer JL; Klatskin G
    Gastroenterology; 1973 Dec; 65(6):929-35. PubMed ID: 4753351
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous use of rifampicin.
    Nilsson BS; Boman G
    Eur J Respir Dis; 1981 Jun; 62(3):212-4. PubMed ID: 7308336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic clearance and urinary excretion of rifamycin in patients with or without liver diseases].
    Rodriguez Garay EA; Laudano OM; Spetale Mdel R
    Farmaco Prat; 1970 Jul; 25(7):423-7. PubMed ID: 5469691
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifampicin: a new rifamycin. 3. Absorption, distribution, and elimination in man.
    Furesz S; Scotti R; Pallanza R; Mapelli E
    Arzneimittelforschung; 1967 May; 17(5):534-7. PubMed ID: 5631581
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bioavailability of 2 different rifampicin preparations].
    Aronne Benach MT; Naranjo Cascante G
    Rev Clin Esp; 1980 Oct; 159(1):43-6. PubMed ID: 7008102
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans].
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Arch Monaldi; 1970; 25(6):427-40. PubMed ID: 5514802
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution and excretion of rifamide in rats and dogs.
    Maffii G; Schiatti P
    Toxicol Appl Pharmacol; 1966 Jan; 8(1):138-51. PubMed ID: 5921889
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary note on the use of parenteral rifampicin (slow venous infusion). Blood levels and tolerance].
    Giura R; Scardaccione M; Roccamo B; Giura C
    G Ital Chemioter; 1978; 25(1):45-8. PubMed ID: 751848
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multicompartimental model for the study of drugs with high biliary excretion, used in the study of the kinetics of rifampicin in man].
    Acocella G; Pagani V; Nicolis FB
    Boll Chim Farm; 1972 Feb; 111(2):108-15. PubMed ID: 5045532
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacology and toxicology of rifamide.
    Dezulian V; Serralunga MG; Maffii G
    Toxicol Appl Pharmacol; 1966 Jan; 8(1):126-37. PubMed ID: 5950859
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of therapeutic activity in tuberculosis of rifamycin SV used locally and intravenously].
    Moncalvo F; Moreo G
    Minerva Med; 1965 Nov; 56(88):3721-7. PubMed ID: 5846624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Local modifications in the vessel walls induced by the intravenous use of rifamycin SV. (Experimental findings)].
    Marcatili S; Del Bono M; Vasaturo G
    Arch Tisiol Mal Appar Respir; 1965 Aug; 20(8):607-23. PubMed ID: 5295553
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary report on the clinical trial of a new antibiotic--Rifocin (rifamycin sv).
    Amaku EO
    West Afr Med J Niger Pract; 1968 Dec; 17(6):281-2 passim. PubMed ID: 4883474
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality assurance: protocol for assessing the rifampicin bioavailability of combined formulations in healthy volunteers.
    Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S284-5. PubMed ID: 10593705
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism and pharmacokinetics of the antibiotic rifampin.
    Kenny MT; Strates B
    Drug Metab Rev; 1981; 12(1):159-218. PubMed ID: 7028436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Several supplementary investigations on rifampicin (rifamycin AMP)].
    Kitamoto O; Fukaya K; Tomori G; Suzuki T
    Jpn J Antibiot; 1970 Jun; 23(3):273-5. PubMed ID: 5312212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.